Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Gross Profit (2016 - 2023)

Historic Gross Profit for Perspective Therapeutics (CATX) over the last 14 years, with Q4 2023 value amounting to -$39000.0.

  • Perspective Therapeutics' Gross Profit changed N/A to -$39000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.4 million, marking a year-over-year decrease of 4843.58%. This contributed to the annual value of $1.4 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Perspective Therapeutics reported Gross Profit of -$39000.0 as of Q4 2023.
  • Over the past 5 years, Perspective Therapeutics' Gross Profit peaked at $1.7 million during Q1 2020, and registered a low of -$39000.0 during Q4 2023.
  • Over the past 5 years, Perspective Therapeutics' median Gross Profit value was $1.1 million (recorded in 2020), while the average stood at $971947.4.
  • In the last 5 years, Perspective Therapeutics' Gross Profit surged by 13587.79% in 2019 and then tumbled by 7321.81% in 2023.
  • Quarter analysis of 5 years shows Perspective Therapeutics' Gross Profit stood at $1.1 million in 2019, then rose by 5.04% to $1.2 million in 2020, then rose by 4.54% to $1.2 million in 2021, then plummeted by 66.07% to $414000.0 in 2022, then plummeted by 109.42% to -$39000.0 in 2023.
  • Its Gross Profit was -$39000.0 in Q4 2023, compared to $738000.0 in Q3 2023 and $248000.0 in Q2 2023.